Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Sep;21(9):1685-7.
doi: 10.3201/eid2109.150461.

Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection

Jan Heyckendorf, Sven Philip Aries, Ulf Greinert, Elvira Richter, Holger Schultz, Christoph Lange
Case Reports

Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection

Jan Heyckendorf et al. Emerg Infect Dis. 2015 Sep.
No abstract available

Keywords: HIV; IL-2; Mycobacterium tilburgii; immunotherapy.

PubMed Disclaimer

Figures

Figure
Figure
Laboratory findings and drug treatment regimen over time for an HIV-infected patient with disseminated Mycobacterium tilburgii infection, December 2006–October 2014. A) CD4+ T cell count, HIV viral load, and use of interleukin-2 (IL-2; gray shading). B) antimycobacterial drug combinations, antiretroviral therapy (ART), and trimethoprim/sulfamethoxazole prophylaxis.
See this image and copyright information in PMC

References

    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416 . 10.1164/rccm.200604-571ST - DOI - PubMed
    1. Hartwig NG, Warris A, van de Vosse E, van der Zanden AG, Schülin-Casonato T, van Ingren J, et al. “Mycobacterium tilburgii” infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis. J Clin Microbiol. 2011;49:4409–11. 10.1128/JCM.05460-11 - DOI - PMC - PubMed
    1. Wagner D, Vos MC, Buiting AGM. “Mycobacterium tilburgii” infections. Emerg Infect Dis. 2006;12:532–4. 10.3201/eid1203.051139 - DOI - PMC - PubMed
    1. Temmerman S, Vandekerckhove L, Sermijn E, Vogelaers D, Claeys G, Vaneerchoutte M, et al. Disseminated infection with Mycobacterium tilburgii in a male immunocompromised patient. J Clin Microbiol. 2014;52:1777–9. 10.1128/JCM.03148-13 - DOI - PMC - PubMed
    1. Palmore TN, Shea YR, Conville PS, Witebsky FG, Anderson VL, Rupp Hodge IP, et al. “Mycobacterium tilburgii,” a newly described, uncultivated opportunistic pathogen. J Clin Microbiol. 2009;47:1585–7. 10.1128/JCM.02385-08 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources